Girl, 12, Underwent 6 Rounds of Unnecessary Chemo After Misdiagnosis, Parents Say Treatment ‘Ruined’ Her Childhood

A 12-year-old girl from Plymouth, England, has been left to face severe health complications after being misdiagnosed with an autoimmune disease. Faye Condon underwent an extensive and unnecessary treatment regimen that included six rounds of chemotherapy, which was ultimately based on an incorrect diagnosis of Juvenile Dermatomyositis (JDM). Her plight has raised questions about medical oversight and the importance of accurate diagnostics in paediatric care.

Faye’s mother, Christina Condon, first became concerned when she noticed her daughter struggled to keep up with her peers in physical activities. At just five years old, Faye was diagnosed with JDM, a condition characterised by muscle weakness and skin rashes. However, Christina’s maternal instincts led her to seek further evaluations at the Bristol Children’s Hospital, located approximately 230 miles from her home.

Christina pursued additional testing amid her growing doubts about the initial diagnosis. Over the course of seven years, Faye endured not only chemotherapy but also invasive procedures like muscle biopsies and home injections. In a twist of fate, it was only after seeking another opinion that Faye was diagnosed with de novo Emery-Dreifuss muscular dystrophy (EDMD) by specialists at Great Ormond Street Hospital (GOSH) in London. EDMD is a genetic disorder known for causing muscle weakness and stiffness over time, with no current cure.

Reflecting on the misdiagnosis, Christina voiced her frustration over the time lost due to unnecessary treatments. “If we had received the correct diagnosis seven years ago, we could have enjoyed holidays and created lasting memories before she became wheelchair-bound,” she lamented. Her experience has been punctuated with grief as she feels their family has been put on hold while hoping for a diagnosis that would indicate her daughter’s recovery.

The initial diagnosis of JDM came in November 2019, and treatment commenced in January 2021. The chemotherapy episodes were reportedly traumatic experiences for both mother and child. In addition to the physical toll of the illness, Faye contracted viral meningitis, a serious side effect stemming from her treatment, which added another layer of distress during an already difficult period.

Despite undergoing numerous tests, Christina reported that all indicators suggested something other than JDM. Frustratingly, a muscle biopsy that hinted towards a congenital muscle disease went unnoticed by the medical team, which Christina suspects may have been influenced by budgetary constraints at the hospital.

After seeking a second opinion at Derriford Hospital, Christina was encouraged to have Faye undergo genetic blood testing that eventually led to the correct diagnosis at GOSH. “All Faye needed was a simple blood test with specific genetic analysis, but it was never requested at Bristol,” Christina explained. The emotional cost of these years has been significant; she expressed feelings of being let down by the medical professionals who were supposed to care for her daughter.

Currently, Faye is navigating the latter stages of her health decline; she has begun to lose mobility in her legs and relies on a ventilator for respiratory support at night. Christina has described her daughter as “a ticking time bomb”, indicating the serious and unpredictable nature of Faye’s condition. The family home has become inadequate for Faye’s needs, prompting urgent consideration for making their living environment safer.

In response to this distressing situation, Christina has initiated a formal complaint against Bristol Children’s Hospital. The health board has yet to respond publicly regarding the allegations raised by Christina and the broader implications surrounding the case.

The experience of the Condon family highlights critical concerns regarding patient diagnosis and treatment, particularly in paediatric healthcare systems. As medical professionals examine this case, it underscores the urgency for thorough investigations and protocols that can prevent similar misdiagnoses and subsequent unnecessary treatments in the future.